Magnet-Controlled Medicines — Andrew York & Maria Ingaramo

Magnetogenetics enables the non-invasive, deep-tissue control of biological molecules using magnetic fields, offering a precise alternative to optogenetics and ultrasound. Maria Ingaramo and Andrew York, pioneers at Nonfiction Labs, detail their approach to engineering magnetically responsive proteins by modifying LOV domains. By leveraging electron transfer mechanisms within these proteins, they create systems that can modulate drug activity or fluorescence in response to external magnetic fields. This technology aims to revolutionize medicine by localizing drug potency to specific sites, such as tumors, thereby reducing systemic toxicity and rescuing previously failed therapeutic candidates. While the field has faced skepticism due to past reproducibility issues, the team’s protein engineering methods produce robust, measurable effects, paving the way for future clinical applications and a new paradigm in remote-controlled biological therapy.